USPTO serial 77045844
ANGIOTECH REDEFINING SUCCESS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BESCH, JAY C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANGIOTECH REDEFINING SUCCESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. Costanza
KEVIN S COSTANZA SEED IP LAW GROUP PLLC701 5TH AVE STE 5400SEATTLE, WA 98104-7064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | cardiovascular grafts; vascular grafts; surgical dressings, namely, vascular dressings; bandages for vascular dressings; biological implants, namely, processed human or animal connective tissue in the nature of collagen implants; medical adhesive tape, namely, umbilical tape; wound dressings, namely, non-invasive topical hemostasis pads; and bronchial dilators; wound fasteners, namely, adhesive gels | ACTIVE | — |
| 010 | medical stents; ophthalmic implants comprised of artificial material; orthopedic implants comprised of artificial material; otolaryngology implants comprised of artificial material; plastic surgery implants comprised of artificial material; genitourinary implants comprised of artificial material; gastrointestinal implants comprised of artificial material; dural implants comprised of artificial material; neurological implants comprised of artificial material; anastomosis devices, namely, medical shunts and neurological shunts; cardiovascular catheters; gastrointestinal catheters; genitourinary catheters; adhesive bands for medical purposes, namely, surgical adhesions barriers; medical devices for use in administering fluids and drugs, namely, cardiovascular infusion lines and cardiovascular ports; angioplasty balloons; implants made of artificial material for use in treatment of the neurological system, namely, dural patches; medical ultrasound apparatus, namely, medical devices with echogenic surfaces produced by coatings that enhance ultrasound imaging and ultrasound imaging in procedures; medical ultrasound apparatus, namely, medical devices with echogenic surfaces produced by mechanical roughening of the surfaces that enhance diagnostic ultrasound imaging and ultrasound imaging medical procedures; medical device for controlling bleeding, namely, hemostatic flow valves; biopsy instruments; punctual occlusion products for medical use, namely, medical introducers and punctal plugs; cannulae; predilators, namely, medical introducers; medical introducers in the nature of coaxial dilators; stents; medical guidewires; catheters; blood vessel catheters; coronary angio-plastic catheters; catheters for interventional radiology; catheter sets consisting primarily of catheters; balloon catheters; central venous catheters; infusion catheters; medical apparatus for placing surgical instruments, namely, retrieval baskets; introducer systems consisting of catheters, medical guidewires, medical syringes and needles for medical use; vascular ports; medical tubing in the nature of peripherally inserted central catheter lines; trans-lumbar sets consisting of catheters, medical guidewires, medical syringes and needles for medical use; connectors for connecting surgical and medical tubing; drainage appliances for surgical procedures, namely, drainage bags for use in radiology, gastroenterology, urology and gynecology; surgical knives, namely, knives used to create incisions for cataract or refractive surgery; surgical and ophthalmic blades, knives and scalpels; surgical blades, namely, scalpel blades; scalpel and medical knife handles; surgical ligature string; sutures; suture materials, namely, dressing forceps, forceps for medical use; needles for medical use, namely, suture needles; needled sutures; medical and surgical needles; surgical staples; surgical clips; surgical knives; protectors and guards for medical needles and other medical sharps; replaceable elements for suture attaching equipment; foreign body retrieval apparatus for medical use, namely, forceps; anastomosis devices, namely, shunts; cloth cushion covers for rigid eye protectors for post surgery eye protection; artificial limbs, eyes and teeth; orthopedic articles and implants, namely, orthopedic joint implants, orthopedic belts, orthopedic braces, orthopedic supports, splints; surgical instruments, namely, trocars and punctures; bone setting machines and instruments, namely, bone drills, and fixation pins; drainage appliances for surgical procedures, namely, drainage tubes and bags; screw dilators, namely, bougies; patient monitoring sensors and apparatus, namely, invasive monitoring equipment in the nature of electrodes and transdermal ports; medical instruments for use in performing biopsies; needles for medical use, namely, biopsy needles; biopsy instruments, namely, biopsy sample guns; biopsy instruments, namely, bone marrow biopsy devices; biopsy instruments, namely, reusable handle biopsy guns; biopsy instruments, namely, adjustable automated aspiration device for use in medical biopsies; surgical and medical apparatus and instruments for use in general surgery, namely, punctum plugs; bone cement delivery instruments for medical use; knives for medical use, namely, cystotomes; hypodermic syringes; hypodermic needles; surgical apparatus and instruments for use in ophthalmic surgery, namely, tumor-excising surgical instrument, cortex extractors, iris retractors, lens loops, and capsulotomy kits and syringes; intravenous sets comprised primarily of intravenous feeding bottles and intravenous feeding tubes; breast biopsy site markers for use in medical procedures; implants made of artificial material in the nature of surgical meshes for medical use, and meshes having drug eluting and bioresorbing functions for use in treating the unwanted growth of tissues at surgical sites; and all of the aforementioned goods having lubricious polymer coatings | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ANGIOTECH REDEFINING SUCCESS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 9, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 9, 2009 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Feb 9, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 8, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 12, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 10, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 10, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 10, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 10, 2008 | PBER | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST | — |
| Mar 9, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 9, 2008 | ALIE | ASSIGNED TO LIE | — |
| Feb 14, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 14, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 14, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 14, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 7, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 7, 2008 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 7, 2008 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 7, 2008 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 8, 2007 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 8, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 8, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 17, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2006 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Nov 22, 2006 | NWAP | NEW APPLICATION ENTERED | — |